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Abstract: In this study, our aim was to develop a new simple technique for isolation of mesenchymal stem cells from
adipose tissue. For this purpose, mesenchymal stem cells were isolated from rat adipose tissue by using the primary explant
culture technique. When the cells became confluent, they were passaged 4 times by using the standard trypsinization
method with trypsin/EDTA solution. Cells at second passage were characterized by using immunofluorescence staining
against CD13 and CD29 markers. The results showed that these cultured cells were positive for CD13 and CD29
markers. Flow cytometry analysis was also done against CD29, CD90, CD54, MHC Class I, CD45, CD106, and MHC
Class II for characterization of mesenchymal stem cells. The results of flow cytometry analysis showed that these cells
were mesenchymal stem cells. Half of the cells were cryopreserved at all passages for future applications. It is thought
that these mesenchymal stem cells can be used in therapy of cardiovascular diseases as an alternative technique in the
near future.
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Introduction
A mesenchymal stem cell (MSC) is characterized
by its self-renewal capacity, long-term viability,
and multilineage differentiation (1,2). Therefore,
biological and clinical interest in MSCs has risen
dramatically over the last 2 decades (3). Ideally,
MSCs for clinical applications should meet certain
criteria: they should be found in abundant quantities
(millions and billions of cells); they should be able to
be collected and harvested by a minimally invasive
procedure; they should be differentiated along
multiple cell lineage pathways in a reproducible
manner; and they should be able to be safely and
effectively transplanted to either an autologous or
allogenic host (3).
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The multilineage potential of adult MSCs from
bone marrow has been characterized extensively.
Adipose tissue is a source of these MSCs that can
differentiate into various cell types, like bone,
cartilage, adipose, muscle, and endothelium (411). These MSCs also meet the criteria previously
described. Therefore, adipose tissue-derived MSCs
have great potential for novel cellular therapies to
repair damaged tissues and in angiogenic therapy.
Heart failure is the terminal stage of many diseases
that affect the myocardium (12,13). Coronary artery
disease leading to ischemia of the human myocardium
is a major cause of heart failure (14,15). However,
coronary reperfusion using pharmacological agents
and percutaneous coronary intervention reduces
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mortality resulting from myocardial infarction. At
present, the only radical treatment for end-stage
congestive heart failure is cardiac transplantation;
however, a shortage of donors is a severe limitation
to this approach, and it requires postoperative
immunosuppressive therapy.
Peripheral vascular disease with critical limb
ischemia may continue into severe muscle tissue
loss or ulcers and be terminated with amputation.
Unfortunately, many patients cannot be helped
with currently available surgical or endovascular
revascularization procedures because of the complex
anatomy of the vascular occlusion and/or the
presence of other risk factors (16). Therefore, several
alternative novel approaches are needed to treat these
cardiovascular diseases. Cell transplantation is one
possible alternative treatment that may be available
in the future. However, this alternative treatment
has to be made easier and faster. The present study
is important in this because it is the first step toward
carrying out such easier and faster alternative
treatments.
Materials and methods
Cell isolation and culture
In this study, MSCs were isolated from subcutaneous
flank adipose tissue of rats (Wistar albino, male, 250300 g). Animal procedures related to tissue isolation
were approved by the Kırıkkale University Ethical
Committee. After the xylazine (Richter Pharma AG,
Austria) (10 mg/kg) and ketamine (Richter Pharma
AG) (50 mg/kg) anesthesia of rats, flank adipose tissue
was collected under sterile conditions. The isolation
procedure was repeated 3 times with 3 inbreedings
of rats and an average of 0.62 g of adipose tissue was
collected per rat (n = 3; n1 = 0.72 g, n2 = 0.57 g, n3 =
0.57 g). Adipose tissue was transferred into transport
medium DMEM/F12 (Biochrom AG, Germany)
containing 10% (v/v) FBS (Biochrom AG) and 0.4%
(v/v) penicillin-streptomycin (Sigma Chemical
Co., USA) in a petri dish and then minced into
fragments of 4-5 mm in thickness. Tissue fragments
were incubated in primary medium (DMEM/F12
containing 20% (v/v) FBS and 0.2% (v/v) penicillinstreptomycin) in a 6-well culture dish under standard
culture conditions (in a humidified atmosphere

of 95% air and 5% CO2 at 37 °C). The culture
medium was replaced every day to avoid possible
differentiative effects of various cytokines originating
from MSCs. Cells were passaged using the standard
trypsinization method and, as they were passaged,
the cell number was counted using the trypan blue
staining method (Sigma Chemical Co.). Trypan
blue is a vital staining used to selectively blue dead
cells. Viable and proliferative cells with intact cell
membranes are not colored. In a viable cell, trypan
blue is not absorbed. Hence, dead cells are shown
with a distinctive blue color under a microscope. The
culture medium was removed and the attached cells
were harvested using trypsin/EDTA (0.05%/0.02;
w/v) solution (Biochrom AG). The cell suspension
was then transferred to a centrifuge tube and
centrifuged at 800 rpm for 5 min to pellet the cells.
The supernatant was removed carefully and the cells
were incubated in DMEM/F12 containing 10% (v/v)
FBS and 0.2% (v/v) penicillin-streptomycin. The
MSCs were passaged 4 times and then cryopreserved
for future applications. For cryopreservation, cells
were detached from the surface of the culture dish by
using a trypsin/EDTA solution. The cell suspension
was immediately transferred into a freezing medium
containing 50% (v/v) FBS, 40% DMEM/F12, and 10%
(v/v) DMSO (Sigma Chemical Co.) in a cryogenic
tube. Cryovials were stored at –80 °C for 48 h and
then the frozen vials were transferred to a liquid
nitrogen container at –196 °C for long-term storage.
For standardization of cell concentrations for future
applications, all cells harvested from the three 6-well
culture dishes were collected in 1 cryogenic tube. Cell
morphology and growth were examined under an
inverted microscope (IX70, Olympus, Japan).
Cell characterization
Mesenchymal stem cells were characterized using
immunofluorescence staining of CD13 and CD29
molecules (Santa Cruz Biotechnology, Inc., USA)
during their second passage. For immunostaining,
cells grown in culture dishes were washed in PBS
(Biochrom AG) and fixed for 5 min in methanol at
–10 °C. After fixation, the methanol was removed and
desiccated. For blocking, the cells were incubated for
20 min with blocking serum (normal goat serum).
After blocking, the blocking serum was removed,
and the cells were washed 3 times in PBS and then
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incubated for 1 h with primary antibody for CD13
and CD29 molecules. After washing for 5 min in PBS,
the cells were incubated for 45 min with a secondary
antibody (donkey antigoat Ig-TR) and washed 3
times in PBS. After washing, the cells were mounted
with mounting medium and visualized under the
fluorescence microscope (BH2-RFL-T3 model
fluorescence attachment, Olympus). All procedures
were done at room temperature. The flow cytometry
analysis was done against CD29, CD90, CD54,
MHC Class I, CD45, CD106, and MHC Class II for
characterization of mesenchymal stem cells. The flow
cytometry analysis was performed at the Kocaeli
University Center for Stem Cell and Gene Therapies
Research and Practice (KOGEM), Kocaeli, Turkey.

Results and discussion
Cell isolation and culture
In this study, cell isolation was performed using the
primary explant culture technique. No enzymatic
digestion method was used. Tissue fragments
obtained from the adipose tissue were plated directly
into 6-well culture dishes. After 18 h of culture, the
emergence of cells with fibroblastic cell morphology
was identified among the erythrocytes (Figures 1a
and 1b).
After 7 days, the number of the cells with
fibroblastic morphology increased and confluency
was observed on distinct parts of the culture plate
(Figures 2a and 2b). Many of the erythrocytes were

b
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Figure 1. Morphological appearance of mesenchymal stem cells derived from adipose tissue at 18 h of culture at a) 10× and b) 20×.
White arrow indicates mesenchymal stem cell and black arrow indicates erythrocytes.
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Figure 2. Mesenchymal stem cells after a) 7 days of culture, with b) confluency observed on distinct parts of the culture plate (10×).
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removed by changing the culture medium, and just
before the first passage, the red blood cells completely
disappeared (Figures 3a and 3b).
Although the cells had not become completely
confluent, they were passaged on day 7 of primary
culture. The cell number was an average of 600,000
cells/mL at the beginning of the first passage for
a 6-well culture dish (n = 3; n1 = 400,000 cells/mL,
n2 = 640,000 cells/mL, n3 = 750,000 cells/mL). After
the first passage, the cell number increased rapidly
compared to primary cells The cell number was
found to be an average of 900,000 cells/mL (n= 3;
n1 = 1,320,000 cells/mL, n2 = 760,000 cells/mL, n3 =
600,000 cells/mL) on day 4 of the first passage.

When the cells became confluent, they were
passaged twice a week. While the culture was
maintained, half of the cells were cryopreserved
after every passage for future applications. The cellreproducing procedure was maintained for 3 weeks.
At the end of this period, a total of 300,000,000 cells
had been obtained per rat (900,000,000 cells for 3
rats).
The fibroblastic cell morphology was also
maintained through repeated subcultures under
nonstimulating conditions after cryopreservation
procedure (Figures 4a and 4b).
In the literature, there are a variety of different
techniques used to isolate MSCs from adipose tissue,

b
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Figure 3. Appearance of cultured cells before first passage at a) 10× and b) 20×. The red blood cells completely disappeared.
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Figure 4. Morphological appearance of confluent cells after second passage at a) 20× and b) 10×.
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many of which are enzymatic methods. For example,
Zuk et al. isolated adipose-derived MSCs from raw
human lipoaspirates in this way. In this method,
raw aspirates were washed with sterile phosphatebuffered saline (PBS) to remove contaminating
debris and red blood cells. Washed aspirates were
treated with 0.075% collagenase (Type I) in PBS
for 30 min at 37 °C with gentle agitation. The
collagenase was inactivated and the cellular pellet
was centrifuged for 10 min, resuspended in culture
medium, and filtered through a 100-µM mesh filter
to remove debris; the cells were then cultured (2).
In another study, fatty tissue was harvested from
the abdominal subcutaneous tissue of New Zealand
white rabbits. The fat was minced and digested with
trypsin and collagenase supplemented with albumin
for 2.5 h in a 37 °C water bath with a magnetic stir
bar. The cells were then centrifuged at 1500 × g for
10 min and the cell pellet was washed and cultured
(5). Cao et al. isolated adipose tissue-derived MSCs
from human raw lipoaspirates by using an enzymatic
digestion method with 0.2% collagenase (6). Katz et
al. isolated MSCs from human subcutaneous adipose
tissue by treating it with enzyme solution (17). In
that study, the dissociated tissue was then filtered
to remove debris and the resulting cell suspension
was centrifuged. In order to lyse erythrocytes, the
cell suspension was treated with an osmotic buffer.
In the most recent studies, MSCs were isolated using
the collagenase digestion method and red blood cells
were removed by treating cells with a lysis buffer
(18,19).

a

In contrast to these studies, in the present study,
neither the collagenase nor trypsin digestion methods
were used, adipose tissue was not filtered, and a lysis
buffer was not used to remove red blood cells. Instead,
MSCs were isolated directly using the explant culture
method. Therefore, this study has some important
advantages in that it is easy, inexpensive, and safe (in
accordance with not using any enzymatic method).
Cell characterization
Adipose tissue-derived MSCs have a specific surface
protein expression, like bone marrow MSCs. Surface
protein expression analysis, which allows for a
rapid identification of a cell population, has been
extensively used (2,20).
In this study, CD13 and CD29 expression was used
to identify MSCs. The result of immunofluorescence
staining showed that these cultured cells were
positive for CD13 and CD29 (Figures 5a and 5b),
and these molecules are surface markers for the
characterization of MSCs (21,22).
These molecules are not only markers, but are
also receptors that play a role in angiogenesis (23).
Therefore, we suggest that they could play a role in
forming new collaterals and in the improvement of
the ischemic myocardium when transplanted into
the damaged tissue.
The results of flow cytometry analysis showed
that these cells were positive for CD29, CD90, CD54,
and MHC Class I, and negative for CD45, CD106,
and MHC Class II. The minimum homogeneity of
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Figure 5. Morphological appearance of cells after immunofluorescence staining: a) CD13 staining at 20×, b) CD29 staining at 10×.
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the mesenchymal stem cells was 98.68% (data not
shown).
MSCs must express some receptors of cytokines,
extracellular matrix components, and growth
factors in order to adhere, proliferate, differentiate,
and migrate. CD29 (integrin β1) plays a role in
MSC adhesion and migration (24). CD90 (Thy1) is a glycophosphatidylinositol (GPI)-anchored
cell surface protein. This protein is a member of the
immunoglobulin superfamily and plays a role in cell
adhesion, extravasation, and migration. CD90 is
commonly used as a positive marker for MSCs (25).
CD54 is also known as intracellular cell adhesion
molecule-1 (ICAM-1). It plays a role in cell signaling,
cell-cell adhesion, and transmigration. CD54 is
important for transmigration of MSCs (26). MSCs
isolated from adipose tissue express high levels of
CD54 (27). MSCs are hypoimmunogenic cells because
of the lack in expression of MHC Class II (28).
MHC Class II molecules are found only on antigenpresenting cells and lymphocytes. Because of the lack
in expression of MHC Class II on MSCs, these cells are
hypoimmunogenic cells. Nevertheless, MSCs express
the MHC Class I molecules. Although initially it was
thought that MSCs could escape natural killer (NK)
cells, it was recently shown that NK cells can efficiently
lyse MSCs, despite the expression of high levels of
HLA-1 by MSCs. However, MHC Class I acts as an
inhibitory ligand for NK cells, and MSCs could suppress
proliferation of NK cells and decrease the secretion of
IFN-g by IL-2-stimulated NK cells. CD45 is a protein

that plays a role in cell growth and differentiation; this
molecule is a hematopoietic cell marker and it is not
found on MSCs (29). CD106, also known as vascular
cell adhesion molecule-1 (VCAM-1), is a protein that
mediates the adhesion of lymphocytes, monocytes,
eosinophils, and basophils to vascular endothelium.
CD106 is negative for MSCs and it is a hematopoietic
and endothelial cell marker (30).
Recent studies have shown that MSCs give good
results in in vivo applications. However, it is not
understood how they do this: by cytokines or by
differentiation. This is a question that remains to be
answered.
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